Genomics and Toxic Torts: Dismantling the Risk-Injury Divide‪.‬

INTRODUCTION Advances in molecular biology and genomics are poised to transform current conceptions of "risk" and "injury" in the law of toxic torts. (1) The legal system has yet to anticipate or plan for this emerging reality. This Article argues that if the law remains wedded to conventional notions of injury, it will ignore the fruits of a scientific revolution and thus may forego new remedial opportunities that could benefit both plaintiffs and defendants in the end.